Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Disease × Lymphoid × Clear all

Phase

Phase 1/2 6 Phase NA 5 Phase 2 2 Phase 1 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 6 Thoracic 5 Plasma cell 4 Endocrine 2 CNS 2 Other hematologic neoplasm 1 NET 1 Lymphoid 1 Head & Neck 1 Breast 1

Conditions

Lymphoma 199 Lymphoma, Follicular 198 Lymphoma, Non-Hodgkin 166 Leukemia, Lymphocytic, Chronic, B-Cell 165 Lymphoma, Large B-Cell, Diffuse 163 Precursor Cell Lymphoblastic Leukemia-Lymphoma 153 Leukemia 89 Hodgkin Disease 89 Lymphoma, Mantle-Cell 80 Lymphoma, B-Cell, Marginal Zone 66 Burkitt Lymphoma 65 Leukemia, Myeloid, Acute 55 Multiple Myeloma 51 Lymphoma, Large-Cell, Immunoblastic 48 Recurrence 44 Neoplasms 38 Myelodysplastic Syndromes 38 Lymphoma, T-Cell, Cutaneous 36 Mycosis Fungoides 30 Lymphoma, Large-Cell, Anaplastic 30 Waldenstrom Macroglobulinemia 28 Leukemia, Myeloid, Chronic-Phase 28 Myeloproliferative Disorders 27 Lymphoma, B-Cell 27 Leukemia, Myeloid, Accelerated Phase 27 Sezary Syndrome 25 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 25 Leukemia, Biphenotypic, Acute 25 Blast Crisis 24 Primary Myelofibrosis 22

Interventions

obinutuzumab 1 Vindesine 1 Vincristine 1 Rituximab 1 Prednisone 1 Doxorubicin 1 Cyclophosphamide 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01659099 2018-03-07

GAINED

The Lymphoma Academic Research Organisation

Phase 3 Terminated

Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡